# A Drug-Drug Interaction Study Between AZD9668 and Warfarin to Study the Effect of AZD9668 on the Metabolism and Effect of Warfarin

> **NCT01214122** · PHASE1 · WITHDRAWN · sponsor: **AstraZeneca**

## Conditions studied

- Pharmacokinetics
- Pharmacodynamics

## Interventions

- **DRUG:** AZD9668
- **DRUG:** Warfarin

## Key facts

- **NCT ID:** NCT01214122
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2010-11
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2013-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01214122

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01214122, "A Drug-Drug Interaction Study Between AZD9668 and Warfarin to Study the Effect of AZD9668 on the Metabolism and Effect of Warfarin". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01214122. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*